These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 2467764)

  • 1. Mechanism of false-negative urine cannabinoid immunoassay screens by Visine eyedrops.
    Pearson SD; Ash KO; Urry FM
    Clin Chem; 1989 Apr; 35(4):636-8. PubMed ID: 2467764
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Determination of five abused drugs in nitrite-adulterated urine by immunoassays and gas chromatography-mass spectrometry.
    Tsai SC; ElSohly MA; Dubrovsky T; Twarowska B; Towt J; Salamone SJ
    J Anal Toxicol; 1998 Oct; 22(6):474-80. PubMed ID: 9788522
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection times of marijuana metabolites in urine by immunoassay and GC-MS.
    Huestis MA; Mitchell JM; Cone EJ
    J Anal Toxicol; 1995 Oct; 19(6):443-9. PubMed ID: 8926739
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Investigation of nitrite adulteration on the immunoassay and GC-MS analysis of cannabinoids in urine specimens.
    Tsai LS; ElSohly MA; Tsai SF; Murphy TP; Twarowska B; Salamone SJ
    J Anal Toxicol; 2000; 24(8):708-14. PubMed ID: 11110026
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detectability of phencyclidine and 11-nor-delta 9-tetrahydrocannabinol-9-carboxylic acid in adulterated urine by radioimmunoassay and fluorescence polarization immunoassay.
    Bronner W; Nyman P; von Minden D
    J Anal Toxicol; 1990; 14(6):368-71. PubMed ID: 1964989
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correlations on radioimmunoassay, fluorescence polarization immunoassay, and enzyme immunoassay of cannabis metabolites with gas chromatography/mass spectrometry analysis of 11-nor-delta 9-tetrahydrocannabinol-9-carboxylic acid in urine specimens.
    Weaver ML; Gan BK; Allen E; Baugh LD; Liao FY; Liu RH; Langner JG; Walia AS; Cook LF
    Forensic Sci Int; 1991; 49(1):43-56. PubMed ID: 1851715
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunoassay and GC-MS procedures for the analysis of drugs of abuse in meconium.
    ElSohly MA; Stanford DF; Murphy TP; Lester BM; Wright LL; Smeriglio VL; Verter J; Bauer CR; Shankaran S; Bada HS; Walls HC
    J Anal Toxicol; 1999 Oct; 23(6):436-45. PubMed ID: 10517548
    [TBL] [Abstract][Full Text] [Related]  

  • 8. False negative GC/MS assay for carboxy THC due to ibuprofen interference.
    Brunk SD
    J Anal Toxicol; 1988; 12(5):290-1. PubMed ID: 2852278
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ONTRAK TESTCUP: a novel, on-site, multi-analyte screen for the detection of abused drugs.
    Towt J; Tsai SC; Hernandez MR; Klimov AD; Kravec CV; Rouse SL; Subuhi HS; Twarowska B; Salamone SJ
    J Anal Toxicol; 1995 Oct; 19(6):504-10. PubMed ID: 8926746
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of RapiTest with Emit d.a.u. and GC-MS for the analysis of drugs in urine.
    Korte T; Pykäläinen J; Lillsunde P; Seppälä T
    J Anal Toxicol; 1997; 21(1):49-53. PubMed ID: 9013293
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The analytical performance of six urine drug screens on cobas 6000 and ARCHITECT i2000 compared to LC-MS/MS gold standard.
    Abou El Hassan M; Colantonio D; Likhodii S; Nassar BA
    Clin Biochem; 2021 Jul; 93():99-103. PubMed ID: 33844982
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analytic performance of immunoassays for drugs of abuse below established cutoff values.
    Luzzi VI; Saunders AN; Koenig JW; Turk J; Lo SF; Garg UC; Dietzen DJ
    Clin Chem; 2004 Apr; 50(4):717-22. PubMed ID: 14764642
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adulteration of urine by "Urine Luck".
    Wu AH; Bristol B; Sexton K; Cassella-McLane G; Holtman V; Hill DW
    Clin Chem; 1999 Jul; 45(7):1051-7. PubMed ID: 10388482
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Confirmation of marijuana, cocaine, morphine, codeine, amphetamine, methamphetamine, phencyclidine by GC/MS in urine following immunoassay screening.
    Mulé SJ; Casella GA
    J Anal Toxicol; 1988; 12(2):102-7. PubMed ID: 3379919
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of ELISAs for opiates, methamphetamine, cocaine metabolite, benzodiazepines, phencyclidine, and cannabinoids in whole blood and urine.
    Kerrigan S; Phillips WH
    Clin Chem; 2001 Mar; 47(3):540-7. PubMed ID: 11238309
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interference of common household chemicals in immunoassay methods for drugs of abuse.
    Warner A
    Clin Chem; 1989 Apr; 35(4):648-51. PubMed ID: 2539273
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of an Automated Reader and Color Interpretation-Based Immunoassays for Multiplexed Drug-of-Abuse Testing in Urine.
    Kim SY; Kim H; Park Y; Lim J; Kim J; Koo SH; Kwon GC
    J Anal Toxicol; 2017 Jun; 41(5):412-420. PubMed ID: 28201761
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A research note: the outcome of GC/MS/MS confirmation of hair assays on 93 cannabinoid (+) cases.
    Mieczkowski T
    Forensic Sci Int; 1995 Jan; 70(1-3):83-91. PubMed ID: 7860039
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Retrospective Analysis of Urine Drugs of Abuse Immunoassay True Positive Rates at a National Reference Laboratory.
    Johnson-Davis KL; Sadler AJ; Genzen JR
    J Anal Toxicol; 2016 Mar; 40(2):97-107. PubMed ID: 26668238
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of forensic specimens for cannabinoids. II. Relationship between blood delta 9-tetrahydrocannabinol and blood and urine 11-nor-delta 9-tetrahydrocannabinol-9-carboxylic acid concentrations.
    Moody DE; Monti KM; Crouch DJ
    J Anal Toxicol; 1992; 16(5):302-6. PubMed ID: 1338218
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.